![]() |
市場調查報告書
商品編碼
1499560
血液透析機/腹膜透析市場:按類型、產品類型、適應症、透析場所 - 全球預測 2024-2030Hemodialysis & Peritoneal Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Products (Hemodialysis Consumables & Supplies, Hemodialysis Equipment), Product Type, Disease Indication, Dialysis Site - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
血液透析機/腹膜透析市場規模預計2023年為843.7億美元,2024年達897.5億美元,預計2030年將達1317.1億美元,複合年成長率為6.56%。
血液透析機和腹膜透析包括用於治療腎衰竭(也稱為末期腎功能衰竭(ESRD))的醫療技術、服務和相關產品。血液透析機(HD) 涉及透過透析器將患者的血液過濾到體外,以去除廢物和多餘的液體。另一方面,在腹膜透析(PD)中,透析液被注入腹膜腔,利用腹膜(覆蓋腹部的膜)作為過濾器來吸收和排放廢物。糖尿病、高血壓和其他慢性疾病的增加是腎臟疾病增加的主要促進因素,從而推動了透析需求。然而,與透析治療和相關衛生服務相關的費用是一個主要障礙,特別是在低收入地區。此外,由於其便利性和潛在的成本效益,患者越來越喜歡家庭透析治療。穿戴式透析設備的開拓有可能使連續透析成為一種負擔較輕且可行的選擇,從而徹底改變市場。此外,將數位醫療服務融入透析護理有可能透過更好的依從性和即時監測來改善患者的治療結果。
主要市場統計 | |
---|---|
基準年[2023] | 843.7億美元 |
預測年份 [2024] | 897.5億美元 |
預測年份 [2030] | 1317.1億美元 |
複合年成長率(%) | 6.56% |
區域洞察
在北美和南美,美國和加拿大由於糖尿病等文明病的高盛行率以及設備齊全的醫療設施,在血液透析機和腹膜透析市場中佔據重要地位。該地區擁有強大的影響力,擁有先進的醫療基礎設施、高額醫療支出以及廣泛的研發活動。醫療保險和其他補助可以幫助您獲得所需的透析治療。同時,不斷成長的老年人口和有利的報銷政策對於歐洲、中東和非洲國家至關重要。由於政府的衛生政策,歐盟的透析治療採用率很高,而且透析很容易取得,而且通常是免費的。此外,中國、日本和印度由於人口眾多且慢性腎臟病(CKD)盛行率不斷上升,因此成為亞太地區的潛在市場。快速都市化、人口老化以及糖尿病和高血壓的增加(慢性腎臟病的主要原因)正在推動這些地區對透析治療的需求。
FPNV定位矩陣
FPNV定位矩陣對於評估供應商在血液透析機和腹膜透析市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對血液透析機和腹膜透析市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在血液透析機和腹膜透析市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Hemodialysis & Peritoneal Dialysis Market size was estimated at USD 84.37 billion in 2023 and expected to reach USD 89.75 billion in 2024, at a CAGR 6.56% to reach USD 131.71 billion by 2030.
Hemodialysis and peritoneal dialysis encompass the medical technologies, services, and associated products used in the treatment of kidney failure, also called as end-stage renal disease (ESRD). Hemodialysis (HD) involves filtering a patient's blood outside the body through a dialysis machine to remove waste products and excess fluids. On the other hand, peritoneal dialysis (PD) uses the patient's peritoneum (a membrane lining the abdomen) as a filter by instilling a dialysis solution into the abdominal cavity to absorb waste products that are drained away. Increasing rates of diabetes, hypertension, and other chronic diseases are primary drivers for the rise in kidney disease, subsequently boosting the demand for dialysis. However, the expense associated with dialysis treatment and related healthcare services is a significant deterrent, particularly in lower-income regions. Moreover, there is a rising trend in patient preference for home dialysis due to its convenience and potential cost-effectiveness. The development of wearable dialysis devices could revolutionize the market by making continuous dialysis a feasible and less intrusive option. In addition, the integration of digital health services in dialysis care could improve patient outcomes through better adherence and real-time monitoring.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 84.37 billion |
Estimated Year [2024] | USD 89.75 billion |
Forecast Year [2030] | USD 131.71 billion |
CAGR (%) | 6.56% |
Regional Insights
In the Americas, the United States and Canada are significant in the hemodialysis & peritoneal dialysis market due to the high prevalence of lifestyle diseases such as diabetes and better healthcare facilities. The region is substantial due to advanced healthcare infrastructure, high spending on healthcare, and extensive research and development activities. Medicare and other subsidies support patient access to necessary dialysis treatments. At the same time, in EMEA countries, an increase in elderly populations and favorable reimbursement policies are pivotal. EU boasts of a high adoption rate of dialysis treatments facilitated by government health policies, ensuring dialysis is accessible and often free at the point of service. Moreover, China, Japan, and India represent potential Asian Pacific markets due to their large populations and increasing prevalence of chronic kidney diseases (CKD). Rapid urbanization, an aging population, and a rise in diabetes and hypertension, which are major contributors to CKD, are driving the demand for dialysis treatments in these areas.
Market Insights
The market dynamics represent an ever-changing landscape of the Hemodialysis & Peritoneal Dialysis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hemodialysis & Peritoneal Dialysis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hemodialysis & Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fresenius Medical Care Secures FDA Clearance for Advanced Hemodialysis System
Fresenius Medical Care announced its receipt of FDA 510(k) clearance for its 5008X Hemodialysis System, marking a significant advancement in dialysis treatment in the United States. This approval paves the way for Fresenius to deliver a new standard of care to American patients suffering from kidney diseases, promising improvements in treatment efficacy and patient well-being with this innovative technology. [Published On: 2024-02-08]
FDA Grants Approval for DefenCath as Antimicrobial Solution for Hemodialysis Patients
The FDA has endorsed DefenCath, developed by CorMedix Inc., a catheter lock solution combining taurolidine and heparin designed for adult patients undergoing chronic hemodialysis via a central venous catheter. This new treatment aims to provide an antimicrobial protective measure for these patients, enhancing the safety and effectiveness of their dialysis procedures. [Published On: 2023-11-15]
Launch of the Inpatient Hemodialysis Program at Rancho Los Amigos National Rehabilitation Center
Rancho Los Amigos National Rehabilitation Center introduces its Inpatient Hemodialysis Program, a significant advancement in the hospital's rehabilitation services. This new initiative highlights Rancho's dedication to medical innovation and underscores its commitment to enhancing patient care. The program is designed to provide comprehensive and continuous care to patients undergoing rehabilitation, ensuring they receive optimal treatment within the facility. This development further establishes Rancho Los Amigos as a leader in implementing forward-thinking healthcare solutions. [Published On: 2023-08-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hemodialysis & Peritoneal Dialysis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Hemodialysis & Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, DaVita Inc., Dialife SA, Evoqua Water Technologies LLC, Fresenius Medical Care AG, Hemoclean Co. Ltd., JMS Co., Ltd., Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical Inc., Rockwell Medical Inc., SB-KAWASUMI LABORATORIES, INC., STERIS Group, Toray Medical Co., Ltd., and Trivitron Healthcare.
Market Segmentation & Coverage